Table 3.
AIMS65 | GBS | RS | |
---|---|---|---|
Inpatient cmortality | 1 (S: 100%; E: 24%; PPV: 12%; NPV: 100%) | 12 (S: 76%; E: 68%; PPV: 19%; NPV: 96%) | 6 (S: 90%; E: 60%; PPV: 19%; NPV: 98%) |
Endoscopic intervention | 1 (S: 87%; E: 28%; PPV: 45%; NPV: 76%) | 9 (S: 75%; E: 44%; PPV: 48%; NPV: 72%) | − |
Rebleeding | − | 11 (S: 77%; E: 54%; PPV: 7%; NPV: 98%) | 6 (S: 69%; E: 56%; PPV: 7%; NPV: 98%) |
Surgery | − | − | − |
Transfusion | 1 (S: 88%; E: 37%; PPV: 69%; NPV: 64%) | 8 (S: 91%; E: 58%, PPV: 78%, NPV: 80%) | 4 (S: 87%; E: 51%; PPV: 75%; NPV: 71%) |
Delayed mortality (6 mo) | 2 (S: 38%; E: 89%; PPV: 31%; NPV: 91%) | 10 (S: 72%; E: 49%; PPV: 16%; NPV: 93%) | 6 (S: 69%; E: 64%; PPV: 20%; NPV: 94%) |
Composite endpoint | 1 (S: 88%; E: 29%; PPV: 49%; NPV: 76%) | 10 (S: 65%; E: 51%; PPV: 51%, NPV: 65%) | 5 (S: 82%; E: 57%; PPV: 60%; NPV: 81%) |
GBS: Glasgow–Blatchford Score; RS: Rockall score; S: sensitivity; E: specificity; PPV: positive predictive value; NPV: negative predictive value